A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals. A case-referent, two-year controlled study

Allergologia et Immunopathologia

Volumn 31, Issue 1, 2003, Pages 31-43

  Cirla, A M ^a   Cirla, P E ^b   Parmiani, S ^c   Pecora, S ^b  

^a CREMONA HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c ALK Abello SpA   (Italy)

Author keywords

Birch pollen allergy; Bronchial hyperresponsiveness; Grass pollen allergy; IgE; IgG; Immunotherapy; Nasal Provocation Tests; Priming; Sublingual administration

Indexed keywords

ANTIHISTAMINIC AGENT; BIRCH EXTRACT; GRASS POLLEN EXTRACT; HAZEL EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIGEN SPECIFICITY; ARTICLE; BIRCH; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CROSS REACTION; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; OUTCOMES RESEARCH; POLLEN ALLERGY; PROVOCATION TEST; SEASONAL VARIATION; SENSITIZATION; TISSUE SPECIFICITY;

EID: 0037282702     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: 10.1157/13042841     Document Type: Article

References (53)

1. Who Position Paper. Allergen Immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997. Allergy 1998;53(Suppl 44):1-42.
2. Koh YT, Choi JW, Lee MH, Sun YH, Lee SI, Lee SY, Oh JW. A preceding airway reaction to one allergen may lead to priming of the airway responses to another allergen. Allergy 1997;52:284-92.
3. Vieira FA, Ferreira EN, Cruz AA. Grass allergy increases the risk of tree pollen sensitization: a warning to urban planners. J Allergy Clin Immunol 1998;102:700-1.
4. Wachs M, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Observation on the pathogenesis of nasal priming. J Allergy Clin Immunol 1989;84:492-501.
5. Rantio-Lehtimaki A, Viander M, Koivikko A. Airborne birch pollen antigens in different particle sizes. Clin Exp Allergy 1994;24:23-8.
6. Arntzen FC, Wilhelmsen TW, Löwenstein H, Gjesing B, Maasch HJ, Stromberg R, Einarsson R, Backman A, Makinen-Kiljunen S, Ford A. The international collaborative study on the first international standard of birch (Betula verrucosa)-pollen extract. J Allergy Clin Immunol 1989;83:66-82.
7. Ricca V, Landi M, Ferrero P, Bairo A, Tazzer C, Canonica GW, Ciprandi G. Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis. J Allergy Clin Immunol 2000;105:54-7.
8. Vignola AM, Bousquet J. Rhinitis and asthma: a continuum of disease?. Clin Exp Allergy 2001;31:674-7.
9. Djukanovic R, Wilson SJ, Howarth PH. Pathology of rhinitis and bronchial asthma. Clin Exp Allergy 1996;26(Suppl 3):44-51.
10. Wallaërt B, Chanez P, Godard P. The nose and lung disease. European Respiratory Monograph, vol 6, Monograph 18. Sheffield UK: ERS Journals, 2001.
11. Valenta R, Breiteneder H, Petternburger K, Breitenbach M, Rumpold H, Kraft D, Scheiner O. Homology of the major birch-pollen allergen, Betv I, with the major pollen allergens of alder, hazel and hornbeam at the nucleic acid level determined by cross-hybridization. J Allergy Clin Immunol 1991;87:677-82.
12. Woschnagg C, Rak S, Venge P. Oxygen radical production by blood eosinophils is reduced during birch pollen season in allergic patients. Clin Exp Allergy 1996;26:1064-72.
13. Crimi E, Voltolini S, Gianiorio P, Orengo G, Troise C, Brusasco V, Crimi P, Negrini AC. Effects of seasonal exposure to pollen on specific bronchial sensitivity in allergic patients. J Allergy Clin Immunol 1990;85:1014-9.
14. Hakansson L, Heinrich C, Rak S, Venge P. Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy. J All Clin Immunol 1997;99:551-62.
15. Winther L, Mailing HJ, Moseholm L, Mosbech LI. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. I. Efficacy estimated by a model reducing the bias of annual differences in pollen counts. Allergy 2000;55:818-26.
16. Winther L, Mailing HJ, Mosbech H. Allergen-specific immunotherapy in birch-and grass-pollen-allergic rhinitis. II. Side effects. Allergy 2000;55:827-35.
17. Frew AJ, Smith HE. Sublingual immunotherapy. J Allergy Clin Immunol 2001;107:441-4.
18. Mailing HJ. Sublingual immunotherapy. Clin Exp Allergy 1996;26:1228-31.
19. Mailing HJ, Abreu-Nogueira J, Alvarez-Cuesta E, Bjorkstön B, Bousquet J, Caillot D, Canonica GW, Passalacqua G, Saxonis-Papageorgiou P, Valovirta E. Local immunotherapy. Allergy 1998;53:933-44.
20. Di Rienzo V, Pagani A, Parmiani S, Passalacqua G, Canonica GW. Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 1999;54:1110-3.
21. Andre C, Vatrinet C, Galvain S, Carat F, Sicard H. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000;121:229-34.
22. Dolz I, Martinez-Cocera C, Bartolomé JM, Cimarra M. A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract Alutard SQ during a 3-year period with initial rush immunotherapy. Allergy 1996;51:489-500.
23. Quirino T, Iemoli E, Siciliani E, Parmiani S, Milazzo F. Sublingual versus injective immunotherapy in grass pollen allergic patients: a double-blind (double dummy) study. Clin Exp Allergy 1996;26:1253-61.
24. Pradalier A, Basset D, Claudel A, Couturier P, Wessel F, Galvain S, André C. Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis. Allergy 1999;54:819-28.
25. Voltolini S, Modena P, Minale P, Bignardi D, Troise C, Puccinelli P, Parmiani S. Sublingual immunotherapy in tree pollen allergy. Double-blind, placebo-controlled study with a biologically standardised extract of tree pollens (alder, birch and hazel) administered by a rush schedule. Allergol Immunopathol (Mad) 2001;29:103-10.
26. Horak F, StObner P, Berger UE, Marks B, Toth J, Jäger S. Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study. J Investig Allergol Clin Immunol 1998;8:165-71.
27. Bjorkstén B, Möller C, Broberger U, Ahlstedt S, Dreborg S, Johansson SG, Juto P, Lanner A. Clinical and immunological effects of oral immunotherapy with a standardized birch pollen extract. Allergy 1986;41:290-5.
28. Taudorf E, Laursen LC, Lanner A, Bjorkstén B, Dreborg S, Soborg M, Weeke B. Oral immunotherapy in birch pollen hay fever. J Allergy Clin Immunol 1987;80:153-61.
29. Mac Mahon B, Pugh T. Epidemiology. Principles and Methods. Boston: Little Brown and Company, 1985.
30. Carreira J, Rubio M, Herrero T, Horak F, Businco L, Wüthrich B, de Prada VB, Berry JB, Lischka G, Brighton WD. Collaborative clinical assay of biological potency of allergen skin test extracts. Clin Allergy 1984;14:503-7.
31. Lombardero M, Gonzalez R, Duffort O, Juan F, Ayuso R, Ventas P, Cortes C, Carreira J. Evaluacion de la actividad biologica total y composicion alergenica de extractos alergenicos. Allergol Immunopathol (Mad) 1986;14:189-98.
32. Carreira J, Lombardero M, Ventas P. New developments in in vitro methods. Quantification of clinically relevant allergens in mass units. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Franke A.M. 1994;87:155-66.
33. Passalacqua G, Villa G, Altrinetti V, Falagiani P, Canonica GW, Mariani G, Bagnasco M. Sublingual swallow or spit?. Allergy 2001;56:578.
34. Bachert C, Keilman A. Zur Sensitivität und Spezifität der intranasalen provokation. Laryngol Rhinol Otol 1988;67:57-60.
35. Fennerty AG, Jones KP, Fifield R, Davies BH. Challenge tests and specific IgE in hay fever sufferers. Clin Allergy 1987;17:365-72.
36. Hargreave FE, Ryan G, Thompson NC, O'Byrne PM, Latimer K, Juniper EF, Dolovich J. Bronchial responsiveness to histamine or metacholine in asthma; measurement and clinical significance. J Allergy Clin Immunol 1981;68:347-55.
37. Nadel J, Pauwels R, Snashall P. Bronchial hyperresponsiveness. Oxford: Blackwell Scientific Publications, 1987.
38. Theobald K, Thiel H, Kallweit C, Ulmer W, König W. Detection of proteins in wheat flour extracts that bind human IgG, IgE, and mouse monoclonal antibodies. J Allergy Clin Immunol 1986;78:470-7.
39. Peat JK, Unger WR, Combe D. Measuring changes in logarithmic data, with special reference to bronchial responsiveness. J Clin Epidemiol 1994;47:1099-108.
40. Cirla AM, Sforza N, Roffi GP, Alessandrini A, Stanizzi R, Dorigo N, Sala E, Della Torre F. Preseasonal intranasal immunotherapy in birch-alder allergic rhinitis. A double-blind study. Allergy 1996;51:299-305.
41. Juliusson S, Bende M. Priming effect of a birch pollen season studied with laser Doppler flowmetry in patients with allergic rhinitis. Clin Allergy 1988;18:615-8.
42. McHugh S. Immunological responses to immunotherapy. Clin Exp Allergy 1996;26:1001-4.
43. Möller C, Dreborg S, Einarsson R. Immunotherapy to deciduous tree pollens: specific IgE and IgG antibody patterns. Clin Allergy 1987;17:551-62.
44. Fanta C, Bohle B, Hirt W, Siemann U, Horak F, Kraft D. Ebner H, Ebner C. Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy Immunol 1999;120:218-24.
45. Iliopoulos O, Proud D, Adkinson NF Jr, Creticos PS, Norman PS, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Effects of immunotherapy on the early, late and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol 1991;87:855-66.
46. Grant JA, Nicodemus CF, Findlay SR, Glovsky MM, Grossman J, Kaiser H, Meltzer EO, Mitchel DQ, Pearlman D, Selner J, Settipane G, Silvers W. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995;95:923-32.
47. Watson WT, Becker AB, Simons FE. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993;91:97-101.
48. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989;83:1013-26.
49. Prieto L, Berto JM, Lopez M, Peris A. Modifications of PD20 and maximal degree of airway narrowing to methacholine after pollen season in pollen sensitive asthmatic patients. Clin Exp Allergy 1993;23:172-8.
50. Madonini E, Briatico-Vangosa G, Pappacoda A, Maccagni G, Cardani A, Saporiti F. Seasonal increase of bronchial reactivity in allergic rhinitis. J Allergy Clin Immunol 1987;79:358-63.
51. Di Lorenzo G, Mansueto P, Melluso M, Morici G, Norrito F, Esposito M, Pellitteri M, Di Salvo A, Colombo A, Candore G, Caruso C. Non-specific airway hyperresponsiveness in mono-sensitive Sicilian patients with allergic rhinitis. Its relationship to total serum IgE levels and blood eosinophils during and out of the pollen season. Clin Exp Allergy 1997;27:1052-9.
52. Rak S, Loewhagen O, Venge P. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein (ECP) in pollen allergic patients. J Allergy Clin Immunol 1988;82:470-80.
53. Pichler CE, Marquardsen A, Sparholt S, Löwenstein H, bircher A, Bischof M, Pichler WJ. Specific immunotherapy with Dermatophagoides pteronyssinus and D. farinae results in decreased bronchial hyperreactivity. Allergy 1997;52:274-83.